Researchers at NYU Langone Health and its Perlmutter Cancer Center have revealed that blood tests could predict the return of skin cancer.Melanoma is a less common form of skin cancer that is more dangerous than other varieties, according to the American Cancer Society. This is because it’s much more likely to spread to other parts of the body if not found and treated early.CANCER REPORT REVEALS SURPRISING NEW DATA ON DEATHS, DIAGNOSESThe new cancer research, published in The Lancet Oncology journal, examined the levels of circulating tumor DNA (ctDNA) found in cancer patients' blood.Approximately 80% of stage 3 melanoma patients who had detectable levels of ctDNA (before they started treatment) went on to experience a return of the cancer later, according to a press release from NYU Langone.Stage 3 melanoma – one of the most aggressive forms of skin cancer – occurs when the cancer has spread to the lymph nodes.POPULAR… ...[TheTopNews] Read More.
4 days ago
